Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Professor Mary Slatter
Newcastle Authors
Title
Year
Full text
Dr Christo Tsilifis
Dr Venetia Bigley
Dr Suzanne Elcombe
Professor Mary Slatter
Professor Mark Pearce
et al.
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study
2025
Professor Mary Slatter
Professor Andrew Gennery
Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working Party
2025
Rebecca Walsh
Dr Zohreh Nademi
Dr Alexandra Laberko
Dr Terence Flood
Dr Eleri Williams
et al.
Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency
2025
Professor Andrew Gennery
Dr Suzanne Elcombe
Professor Mary Slatter
Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care
2025
Rokas Navickas
Dr Helen Griffin
Dr Manisha Ahuja
Angela Grainger
Professor Mary Slatter
et al.
A de novo TLR7 gain-of-function mutation causing severe monogenic lupus in an infant
2024
Dr Su Han Lum
Dr Geoff Shenton
Professor Sophie Hambleton
Professor Andrew Gennery
Professor Mary Slatter
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts
2024
Professor Mary Slatter
Professor Andrew Gennery
Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency—Centromeric Instability—Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study
2024
Dr Zohreh Nademi
Dr Geoff Shenton
Helen Watson
Emma Matthews
Kay Carruthers
et al.
CD3
+
TCRαβ/CD19
+
-depleted stem cell boost and CD45RO
+
memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT
2024
Dr Karin Engelhardt
Dr Helen Griffin
Dr Ina Schim van der Loeff
Professor Mary Slatter
Dr Terence Flood
et al.
Expanding the PRAAS spectrum:
De novo
mutations of immunoproteasome subunit b- type 10 in six infants with SCID-Omenn syndrome
2024
Dr Christo Tsilifis
Dr Suzanne Elcombe
Dr Venetia Bigley
Dr Alexandra Laberko
Professor Andrew Gennery
et al.
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study
2024
Dr Su Han Lum
Dr Alexandra Laberko
Professor Andrew Gennery
Professor Mary Slatter
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity
2024
Professor Andrew Gennery
Professor Mary Slatter
Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival
2024
Professor Mary Slatter
Dr Zohreh Nademi
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity
2023
Dr Christo Tsilifis
Dr Eleri Williams
Professor Mary Slatter
Professor Andrew Gennery
Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers
2023
Dr Peter Carey
Dr Scott Marshall
Dr Geoff Shenton
Dr Tina Biss
Professor Roderick Skinner
et al.
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutation
2023
1
2
3
4
5
6
7
8
9
10
11
12
13
14